|
US6319687B1
(en)
*
|
1992-09-24 |
2001-11-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
|
|
US5840686A
(en)
*
|
1992-09-24 |
1998-11-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use
|
|
US6451763B1
(en)
|
1992-06-04 |
2002-09-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Retinal pigmented epithelium derived neurotrophic factor and methods of use
|
|
US7258983B2
(en)
|
1994-04-25 |
2007-08-21 |
Genentech, Inc. |
Cardiotrophin-1 compositions and methods for the treatment of tumor
|
|
WO1995029237A1
(en)
*
|
1994-04-25 |
1995-11-02 |
Genentech, Inc. |
Cardiotrophin and uses therefor
|
|
US6472585B1
(en)
|
1994-04-25 |
2002-10-29 |
Genentech, Inc. |
Cardiotrophin-1 defective mouse
|
|
US5534615A
(en)
*
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US5804376A
(en)
*
|
1995-05-02 |
1998-09-08 |
Incyte Pharmaceuticals, Inc. |
Pancreas-derived serpin
|
|
US7105496B2
(en)
|
1998-07-23 |
2006-09-12 |
Northwestern University |
Methods and compositions for inhibiting angiogenesis
|
|
US6797691B1
(en)
|
1997-07-23 |
2004-09-28 |
Northwestern University |
Methods and compositions for inhibiting angiogenesis
|
|
WO1999004806A1
(en)
*
|
1997-07-23 |
1999-02-04 |
Northwestern University |
Methods and compositions for inhibiting angiogenesis
|
|
US6821775B1
(en)
|
2000-02-11 |
2004-11-23 |
Genvec, Inc. |
Viral vector encoding pigment epithelium-derived factor
|
|
EP1265627B1
(en)
*
|
2000-02-23 |
2008-11-05 |
Northwestern University |
Pharmaceutical compositions for inhibiting angiogenesis by pedf fragments
|
|
US20030158112A1
(en)
|
2002-02-15 |
2003-08-21 |
Johns Hopkins University School Of Medicine |
Selective induction of apoptosis to treat ocular disease
|
|
US20040166091A1
(en)
|
2003-02-24 |
2004-08-26 |
Genvec, Inc. |
Materials and methods for treating disorders of the ear
|
|
WO2006046584A1
(ja)
*
|
2004-10-26 |
2006-05-04 |
Santen Pharmaceutical Co., Ltd. |
視細胞障害治療剤
|
|
CA2588093A1
(en)
*
|
2004-11-16 |
2006-05-26 |
Rony Seger |
Variants of pigment epithelium derived factor and uses thereof
|
|
WO2006064512A1
(en)
*
|
2004-12-13 |
2006-06-22 |
Unichem Laboratories Limited |
A process of fractionating and storing proteins
|
|
AU2006313318B2
(en)
|
2005-11-14 |
2012-04-05 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved variants of pigment epithelium derived factor and uses thereof
|
|
US9938328B2
(en)
*
|
2012-09-17 |
2018-04-10 |
Mackay Memorial Hospital |
Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
|
|
TWI710635B
(zh)
|
2014-10-09 |
2020-11-21 |
美商珍維克公司 |
編碼人類無調同源物-1(hath1)之腺病毒載體
|
|
JP6522063B2
(ja)
*
|
2017-08-10 |
2019-05-29 |
マクカイ メモリアル ホスピタル |
脱毛症及び／又は毛髪色素脱失を治療するためのｐｅｄｆ由来のポリペプチドの使用
|
|
JP2022501056A
(ja)
*
|
2018-09-27 |
2022-01-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
細胞に基づく治療または処置のためのアッセイ
|